SCHEMBL8081175

SCHEMBL8081175

CSc1ccc2nc(S)[nH]c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.44
▸ HPGD P15428 4/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ CYP1A2 P05177 4/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ TYMS P04818 1/20 0.42
▸ LMNA P02545 4/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ NR1I2 O75469 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CHEK1 O14757 1/20 0.36
▸ PRKD3 O94806 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12892268 0.86 ALDH1A1 (0.40) ALDH1A1HPGDSMN1; SMN2HSD17B10TYMS
SCHEMBL16809191 0.80 ALDH1A1 (0.58) ALDH1A1HPGDSMN1; SMN2CYP1A2HSD17B10
SCHEMBL11546307 0.79 TYMS (0.60) ALDH1A1HPGDSMN1; SMN2CYP1A2HSD17B10
SCHEMBL8502461 0.79 HPGD (0.51) ALDH1A1HPGDSMN1; SMN2CYP1A2HSD17B10
SCHEMBL18932089 0.76 ALDH1A1 (0.55) ALDH1A1HPGDSMN1; SMN2CYP1A2HSD17B10
SCHEMBL229608 0.76 KMT2A (0.58) ALDH1A1HPGDSMN1; SMN2CYP1A2HSD17B10
SCHEMBL29822916 0.75 ALDH1A1 (0.37) ALDH1A1HPGDSMN1; SMN2CYP1A2HSD17B10
SCHEMBL28822617 0.75 ALDH1A1 (0.37) ALDH1A1HPGDSMN1; SMN2CYP1A2HSD17B10
SCHEMBL23717308 0.75 ALDH1A1 (0.77) ALDH1A1HPGDSMN1; SMN2CYP1A2HSD17B10
Fluoride SCHEMBL31379728 0.74 KMT2A (0.56) ALDH1A1HPGDSMN1; SMN2CYP1A2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6043242-A TREATING A MAMMAL AFFLICTED WITH A DISEASE BASED ON HELICOBACTER BACTERIA BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 2000-03-28 — — US disclosed
EP-0946559-A2 IMIDAZOPYRIDAZINES Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1999-10-06 — — EP disclosed
WO-1998028299-A2 IMIDAZOPYRIDAZINES BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1998-07-02 — — WO disclosed
Send feedback